News ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid FieldTwo…Promis Neuro AdminFebruary 2, 2021
News ProMIS Neurosciences Announces Strategic Priorities for 2021TORONTO,…Promis Neuro AdminJanuary 12, 2021
News PROMIS NEUROSCIENCES COMPLETES OFFERING OF SPECIAL WARRANTSNOT…Promis Neuro AdminNovember 16, 2020
News ProMIS Neurosciences Announces Third Quarter 2020 ResultsTORONTO,…Promis Neuro AdminNovember 11, 2020
News ProMIS Neurosciences offers comments on recent FDA Advisory Committee meeting on aducanumab for the treatment of Alzheimer’s diseaseFDA…Promis Neuro AdminNovember 9, 2020